Jane Street’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-589
| Closed | -$14.7K | – | 5945 |
|
|
2024
Q4 | $14.7K | Buy |
+589
| New | +$14.7K | ﹤0.01% | 5646 |
|
|
2024
Q3 | – | Sell |
-297
| Closed | -$8.36K | – | 6152 |
|
|
2024
Q2 | $8.36K | Sell |
297
-2,596
| -90% | -$73.1K | ﹤0.01% | 5922 |
|
|
2024
Q1 | $868K | Buy |
2,893
+2,322
| +407% | +$697K | ﹤0.01% | 3388 |
|
|
2023
Q4 | $135K | Buy |
571
+371
| +186% | +$87.6K | ﹤0.01% | 5164 |
|
|
2023
Q3 | $30K | Buy |
+200
| New | +$30K | ﹤0.01% | 4835 |
|
|
2023
Q2 | – | Sell |
-267
| Closed | -$33.7K | – | 5571 |
|
|
2023
Q1 | $33.7K | Buy |
267
+19
| +8% | +$2.4K | ﹤0.01% | 5186 |
|
|
2022
Q4 | $75.1K | Buy |
+248
| New | +$75.1K | ﹤0.01% | 4786 |
|
|
2022
Q3 | – | Sell |
-192
| Closed | -$11K | – | 5960 |
|
|
2022
Q2 | $11K | Buy |
+192
| New | +$11K | ﹤0.01% | 5223 |
|
|
2021
Q3 | – | Sell |
-386
| Closed | -$90K | – | 5449 |
|
|
2021
Q2 | $90K | Buy |
386
+271
| +236% | +$63.2K | ﹤0.01% | 4776 |
|
|
2021
Q1 | $35K | Buy |
+115
| New | +$35K | ﹤0.01% | 4781 |
|
|
2020
Q2 | – | Sell |
-162
| Closed | -$37K | – | 4160 |
|
|
2020
Q1 | $37K | Buy |
+162
| New | +$37K | ﹤0.01% | 3268 |
|
|
2019
Q1 | – | Sell |
-121
| Closed | -$114K | – | 3456 |
|
|
2018
Q4 | $114K | Buy |
+121
| New | +$114K | ﹤0.01% | 2930 |
|